To read the full story, subscribe or sign in.

Zentalis Pharmaceuticals receives $20 million series A financing to set up Chinese JV

May 20, 2020

HONG KONG – New York and San Diego-based Zentalis Pharmaceuticals Inc. has gained $20 million in a series A financing round to support a Chinese joint venture called Zentera Therapeutics.

BioWorld Financings Joint venture Cancer Series A China

Free access to BioWorld coronavirus articles

BioWorld

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

H5N8 avian flu emerges as next public health concern

BioWorld

In their latest submission to Science, Weifeng Shi, director and professor at the Institute of Pathogen Biology at Shandong First Medical University in China, and...

Pfizer vaccine less effective against India variant of SARS-CoV-2

BioWorld

LONDON – A new U.K. study indicates the Pfizer Inc./Biontech SE COVID-19 vaccine is less effective against the India variant of the SARS-CoV-2 virus that was...

Novo to launch weekly weight loss drug Wegovy at same price as daily shot

BioWorld

Novo Nordisk A/S will this month launch its weekly weight loss glucagon-like peptide-1 injection Wegovy (semaglutide) at the same monthly cost as its older daily...

H5N8 avian flu emerges as next public health concern

BioWorld Asia

In their latest submission to Science, Weifeng Shi, director and professor at the Institute of Pathogen Biology at Shandong First Medical University in China, and...